We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

22 hedge funds and large institutions have $12M invested in MorphoSys AG American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 2322 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

30% less capital invested

Capital invested by funds: $17.3M → $12M (-$5.26M)

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
6
Reduced
7
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TI
26
Trexquant Investment
Connecticut
-$104K -15,273 Closed
ECM
27
ExodusPoint Capital Management
New York
-$72K -10,558 Closed
QT
28
Quantbot Technologies
New York
-$7K -1,100 Closed
JP Morgan Chase
29
JP Morgan Chase
New York
-$4K -631 Closed

MOR Hedge Fund Activity: Q2 2022 in Review

22 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q2 2022, worth a combined $12M — down 30% from $17.3M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MOR and 7 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 6 added.

The largest buyer was Hudson Bay Capital Management, adding an estimated $1.79M. The largest seller was Candriam SCA, cutting an estimated $1.16M.

  • 22 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q2 2022, down from 23 in Q1 2022.
  • Funds reported $12M of MorphoSys AG American Depositary Shares stock for Q2 2022, down 30% quarter-over-quarter.
  • 7 funds opened new MorphoSys AG American Depositary Shares positions in Q2 2022 and 8 closed out, a net change of -1 holder.
  • The largest MorphoSys AG American Depositary Shares buyer in Q2 2022 was Hudson Bay Capital Management, an estimated $1.79M added.
  • The largest MorphoSys AG American Depositary Shares seller in Q2 2022 was Candriam SCA, an estimated $1.16M sold.

Based on aggregated 13F filings for Q2 2022.